Donation of Post Mortem Tumor Tissues

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 11, 2016

Primary Completion Date

December 30, 2021

Study Completion Date

April 30, 2022

Conditions
NSCLC Stage IVCRCCUP
Interventions
OTHER

Proteomic analysis

Proteomic analysis of tissues collected from all sites of disease, guided by either imaging performed prior to the patient's death or post-mortem findings. Peripheral blood mononuclear cells (PBMC) will be collected with the purpose of identifying somatic changes occurring specifically in the tumor cells and not in normal DNA of the same patient.

Trial Locations (1)

20162

ASST GOM Niguarda, Milan

All Listed Sponsors
collaborator

University of Turin, Italy

OTHER

collaborator

Fondazione del Piemonte per l'Oncologia

OTHER

lead

Niguarda Hospital

OTHER

NCT03385980 - Donation of Post Mortem Tumor Tissues | Biotech Hunter | Biotech Hunter